INSPIRE Veterinary Partners officer granted 34,247 options exercisable 05/28/2025

Rhea-AI Filing Summary

INSPIRE Veterinary Partners officer Kees Lynley acquired 34,247 stock options exercisable immediately on 05/28/2025 with an exercise price of $1.52. Each option converts into one share of Class A Common Stock and the options expire on 05/28/2035. Following the transaction, the reporting person directly beneficially owns 34,247 derivative securities.

Insights

Financial Analyst

TL;DR: Routine executive option grant of 34,247 options at a low exercise price; limited immediate market impact.

The Form 4 reports a direct acquisition of 34,247 stock options by the company's Chief People Officer, exercisable on 05/28/2025 and expiring on 05/28/2035, with an exercise price of $1.52. This appears to be a standard equity compensation award aligning the officer with shareholder interests. The filing itself does not disclose any cash paid for exercise beyond the stated exercise price or any disposition of existing holdings.

Corporate Governance Expert

TL;DR: Option grant is routine but the filing notes a late submission, reflecting a minor compliance lapse.

The disclosure confirms a direct beneficial ownership change of 34,247 options and explicitly states the Form 4 was filed late due to an "inadvertent administrative error." While the transaction details are standard for executive equity awards, the late filing is a governance/controls issue that the company should address to ensure timely insider reporting going forward. The document does not indicate any corrective actions or whether this affected any insider trading windows.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kees Lynley

Role Chief People Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	34,247	$0.00	--

Holdings After Transaction: Stock Option (right to buy) — 34,247 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kees Lynley

(Last) (First) (Middle)

780 LYNNHAVEN PARKWAY

SUITE 400

(Street)

VIRGINIA BEACH VA 23452

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INSPIRE VETERINARY PARTNERS, INC. [ IVP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief People Officer

3. Date of Earliest Transaction (Month/Day/Year)
05/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$1.52	05/28/2025		A		34,247		05/28/2025	05/28/2035	Class A Common Stock	34,247	$0	34,247	D

Explanation of Responses:

Remarks:

This Form 4 is being filed late due to inadvertent administrative error.

	/s/ Lynley Kees	08/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did IVP report on this Form 4?

The report shows acquisition of 34,247 stock options (right to buy Class A Common Stock) exercisable 05/28/2025 and expiring 05/28/2035.

Who is the reporting person in the IVP Form 4?

The reporting person is Kees Lynley, identified as an officer (Chief People Officer) of INSPIRE Veterinary Partners.

What is the exercise price of the options reported for IVP?

The exercise (conversion) price reported for the derivative securities is $1.52 per share.

How many shares does each option convert into and how many are owned after the transaction?

Each option converts into one share of Class A Common Stock; the reporting person beneficially owns 34,247 such derivative securities following the transaction.

Was the Form 4 filed on time?

No. The filing includes a remark stating it "is being filed late due to inadvertent administrative error."